XTalks

DECEMBER 8, 2021

For the time being, Cambya will be produced in Europe and will run on plug-and-play business models, helping food and beverage brands reformulate their consumer packaged goods (CPG) products. Sweet gives manufacturers the flexibility to completely switch their sweetening system or balance it with standard sugar or sweeteners. “We

Branding 121

Branding Manufacturing Marketing Production 121

Pharmaceutical Technology

SEPTEMBER 8, 2022

Packaging. • Test method development. The information contained within the download document is intended for pharmacists, pharmaceutical executives, sales managers, manufacturers, business development managers, pharmaceutical sales representatives, and any other individual involved in the pharmaceutical compounding sector.

Marketing 100

Marketing Pharmacy Containment Sales 100

Pharmaceutical Technology

MAY 11, 2008

Data has long been incorporated into drug packaging to accomplish these goals, but only to a partial degree with embossed lot numbers, expiry dates and even Braille identification in addition to linear bar codes. For example, Turkey will require track and trace by 1 January 2009 and California is requiring the technology by 1 January 2011.

Drugs 100

Drugs Packaging Packaging Production 100

XTalks

JUNE 14, 2023

Its specialized project marketplace, known as PartnerMatch, serves as an effective tool for stakeholders on both the supply and demand sides, enabling them to locate partners and enhance collaboration within the globally expansive consumer packaged goods market, valued in the trillions.

Contract Manufacturing 98

Contract Manufacturing Manufacturing Branding Packaging 98

Pharmaceutical Technology

NOVEMBER 9, 2022

Ada Palmadottir, Controlant’s vice-president of business development, gives the example of sea freight shipping: “[if] there are delays in the vessels’ departure, you can step in and ship something with air freight to be on time for the market.”. Visibility that’s not accessible in real time isn’t really visibility at all.

Big Data 130

Big Data Manufacturing Vaccination Vaccine 130

The Pharma Data

NOVEMBER 17, 2020

We also look forward to welcoming Sporogenics to JLABS @ Shanghai,” said Peter Hawkes, Head of Business Development, Medical Devices Asia Pacific, Johnson & Johnson. “At MAV participated in the MedTech Innovator Asia Pacific Accelerator program. The MedTech Innovator Asia Pacific Program is held in partnership with APACMed.

Packaging 52

Packaging Packaging Business Development Development 52

Intouch Solutions

NOVEMBER 16, 2021

Today, her experience spans consumer packaged goods, finance, technology, and pharmaceutical, where her passion lies. CHICAGO, IL (November 16, 2021) – Intouch Group, a full-service global agency network serving the pharmaceutical industry, recently announced the promotion of Tina Breithaupt to SVP, Media Services.

Development 52

Development Life Science Packaging Packaging 52

XTalks

JANUARY 5, 2023

She interviewed Bradley Saxe, President of Mainline Foods, and Chef Michael Sanguinetti, business development and market specialist at INTUEAT, to hear their food and beverage industry predictions for the coming year. After discussing each trend, the team weighs in to provide further insights.

Business Development 52

Business Development Marketing Development Packaging 52

XTalks

JANUARY 20, 2021

“The team jumped at the chance to innovate,” says Chris Lopes, the head of Global Business Development for iLab, in an article published by Lab Manager. He describes how the team went directly to customers to learn about their needs for a novel calendaring solution that would facilitate social distancing.

Research 97

Research Reagent Marketing Packaging 97

pharmaphorum

DECEMBER 9, 2021

Within global external innovation the pharma, medical devices and consumer health businesses of Johnson and Johnson share the mission to innovate to transform health for humanity.

Allergies 105

Allergies Life Science Development Scientist 105

The Pharma Data

DECEMBER 8, 2020

Now poised to advance a robust therapeutics pipeline to clinical development, Nuance will use the funds for ongoing R&D of existing products and business development of potential new assets. Through its Shielded Living Therapeutics platform, the company is developing functional cures for chronic diseases.

RNA 52

RNA Antibody Life Science Protein 52

pharmaphorum

AUGUST 1, 2022

Ties Kroezen, venture leader of Community Life Centers and business development manager for Philips Africa, tells us about the challenges present within the African healthcare system, solutions the company developed to help patients and providers connect, and how pharma can assist with delivering better care to African residents.

Development 78

Development Pharma Companies Drugs Life Science 78

The Pharma Data

AUGUST 3, 2021

Revenue growth was 12 percent when excluding effects of 2020 COVID-related stocking patterns, revenue from COVID-19 antibodies and recent business development. Business Development/Other Developments. In the second quarter of 2021, the company recognized acquired in-process research and development charges of $25.0

Antibody 52

Antibody Sales Development Production 52

XTalks

AUGUST 2, 2023

They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. 2) Paxlovid (nirmatrelvir/ritonavir) Paxlovid is a dual-packaged oral medication for the treatment of COVID-19.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

JULY 6, 2021

At its Investor Update, GSK announced a package of new financial outlooks and ambitions. The £33 billion sales ambition is before any significant revenue contribution from early-stage pipeline assets or any contribution from business development. Outlooks for New GSK represent a step-change in growth and performance.

Sales 52

Sales Vaccination Vaccine Production 52

The Pharma Data

AUGUST 3, 2021

Research & Development (R&D) expenses increased 12% primarily due to higher research and early pipeline spend and late-stage development program spend, including our recent business development activities. Acquired IPR&D expenses in 2021 were driven by the Five Prime Therapeutics acquisition.

Sales 52

Sales Production Antibody Development 52

The Pharma Data

NOVEMBER 5, 2020

Corporate and Business Development Update. The Company’s 2020 financial guidance does not assume the completion of any significant business development transactions not completed as of the date of this press release. (4). government.

Sales 40

Sales Production Manufacturing Antibody 40

Pharma Marketing Network

OCTOBER 27, 2020

And so you’re involved in these companies, how does that play into your overall role as a thought leader in the healthcare space?

Insulin 52

Insulin Marketing Doctor Doctors 52

Pharma Marketing Network

OCTOBER 27, 2020

And so you’re involved in these companies, how does that play into your overall role as a thought leader in the healthcare space?

Insulin 52

Insulin Doctor Doctors Marketing 52

The Pharma Data

AUGUST 6, 2020

Management believes that measuring revenue rates on a comparable pro forma basis is an appropriate way for investors to best understand the underlying performance of the business. One can also identify forward-looking statements by the fact that they do not relate strictly to historical or current facts.

Production 52

Production Branding Marketing Containment 52

Pharmaceutical Technology

JUNE 19, 2023

Staying informed of regulatory changes is crucial for businesses to ensure continued compliance and avoid disruptions in their operations. Luigi Galuffo is business development director and based in Germany, where the company houses its site, capable of providing storage for temperatures as low as -80°C.

Medicine 130

Medicine Production Packaging Packaging 130